HSF1 and hepatocellular carcinoma: The immunohistochemistry results demonstrated that 96.2% (n=25/26) of the poorly differentiated HCC, 61.3% (n=19/31) of the moderately differentiated HCC and 20% (n=2/10) of the well-differentiated HCC patients were HSF1-positive.